Other languages Neurogene Inc.

Equities

NGNE

US64135M1053

Market Closed - Nasdaq Other stock markets 02:00:01 04/05/2024 am IST			5-day change	1st Jan Change
36.63 ^USD	+3.50%		+22.26%	+89.01%

29/04	Leerink Partners Starts Neurogene With Outperform Rating, $46 Price Target	MT
22/03	North American Morning Briefing : Stocks Struggle After New Records	DJ

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Neurogene Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
Neurogene Inc. Announces Expansion and Plans for More Rapid Patient Enrollment of Rett Syndrome Gene Therapy Clinical Trial	04/03
Neurogene Inc. Appoints Donna Cochener as Senior Vice President, General Counsel	22/02
Neurogene Inc. Appoints Julie Jordan as Chief Medical Officer	17/01
Neurogene Names Julie Jordan as Chief Medical Officer	17/01
Neurogene Announces Appointment of Julie Jordan, M.D., as Chief Medical Officer	16/01
Neurogene Announces Business Update and 2024 Outlook	05/01
Neurogene Completes Merger With Neoleukin Therapeutics	19/12
Neurogene Inc. completed the acquisition of Neoleukin Therapeutics, Inc. from a group of shareholders for approximately $120 million in a reverse merger transaction.	18/12
Neoleukin Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Sector Update: Health Care Stocks Rise Slightly Late Afternoon	23/23/23
Sector Update: Health Care Stocks Mixed Friday Afternoon	22/23/22
Neoleukin Therapeutics Board Approves 1-for-5 Reverse Stock Split	22/23/22
Neoleukin Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/23/11
Neoleukin Therapeutics to Merge With Neurogene in All-Stock Deal	18/23/18
Neoleukin Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	09/23/09
Neoleukin Therapeutics, Inc. Appoints Donna M. Cochener as the Interim Chief Executive Officer	04/23/04
Neoleukin Therapeutics, Inc. Announces Board Changes	10/23/10
Sector Update: Healthcare Stocks Stumble Late	10/23/10
Sector Update: Health Care Stocks Seeking Direction Again	10/23/10

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Neurogene Inc.

Equities

NGNE

US64135M1053

Other languages

Filters